By Deirdre Saulet and Kate Wister
Precision medicine brings the promise of providing more targeted treatment to cancer patients—as a result, it has generated a lot of excitement among cancer providers, administrators, and patients. But as the field rapidly evolves, cancer programs are challenged to stay on top of advances, make informed investments, and help providers put precision medicine into practice.
Read on to learn what over 170 programs that participated in our Trending Now in Cancer Care survey told us about how they offer molecular testing and immunotherapy to their patients.
Next, Check Out
2017 survey results: The top cancer program threats and opportunities